Richard Paxman, Chief Executive Officer of Paxman Scalp Cooling, shares his exporting journey.
Huddersfield headquartered medical technology company, Paxman has an established leadership position in the Scalp Cooling sector, manufacturing and supplying the Paxman Scalp Cooling System (PSCS) to over 60 markets internationally.
Paxman’s medical device is used by patients around the world to minimise the side effect of chemotherapy-induced alopecia (CIA). This side effect is widely recognised as one of the most traumatic associated with cancer treatment.
Paxman have a research centre at the University of Huddersfield and is looking to commercialise two new products in the next 12-24 months.
Paxman exports to 60 markets globally, with offices in Canada, Sweden and the USA, and regional managers in France, India, Spain and Singapore.
The USA continues to be a key focus for the business however Asia will become more significant through 2024 with a potential launch in China hopefully thereafter.
Richard Paxman comments, “I am incredibly passionate about exporting and strongly believe it can be the answer to growth and improved productivity. Export is 90% of our business and the USA is 50% of our total business. Our vision is that no matter where in the world you are, no matter who you are, nor your financial position, you have access to our technology. For me, the top tip is that export is all about relationships. Ensure you understand the market, the people, the place, the regulatory environment and how you will get paid. The best way to do this is by getting on a plane, visiting the market, and beginning to build relationships. We often joke in my international team #ToGrowWeMustFly.”
Business supported & Case study obtained through the Department for Business and Trade.
Find out how the Department for Business and Trade can help you.
